Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00618345 · COMPLETED

Trial details

NCT number: NCT00618345
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma and Plasma Cell Neoplasm

Start date: 2005-03-01
Primary completion: 2006-10-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.